Pfizer Inc. (PFE)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
At close: 04:03PM EST
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 290.66B |
| Enterprise value | 290.21B |
| Trailing P/E | 9.92 |
| Forward P/E | 10.42 |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 2.98 |
| Price/book (mrq) | 3.14 |
| Enterprise value/revenue | 2.91 |
| Enterprise value/EBITDA | 7.36 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.65 |
| 52-week change 3 | -1.89% |
| S&P500 52-week change 3 | -15.89% |
| 52-week high 3 | 61.71 |
| 52-week low 3 | 41.45 |
| 50-day moving average 3 | 46.59 |
| 200-day moving average 3 | 49.13 |
Share statistics
| Avg vol (3-month) 3 | 20.35M |
| Avg vol (10-day) 3 | 20.25M |
| Shares outstanding 5 | 5.61B |
| Implied shares outstanding 6 | N/A |
| Float 8 | 5.61B |
| % held by insiders 1 | 0.05% |
| % held by institutions 1 | 70.49% |
| Shares short (14 Nov 2022) 4 | 70.04M |
| Short ratio (14 Nov 2022) 4 | 3.04 |
| Short % of float (14 Nov 2022) 4 | 1.25% |
| Short % of shares outstanding (14 Nov 2022) 4 | 1.25% |
| Shares short (prior month 13 Oct 2022) 4 | 62.51M |
Dividends & splits
| Forward annual dividend rate 4 | 1.6 |
| Forward annual dividend yield 4 | 3.09% |
| Trailing annual dividend rate 3 | 1.59 |
| Trailing annual dividend yield 3 | 3.07% |
| 5-year average dividend yield 4 | 3.59 |
| Payout ratio 4 | 30.46% |
| Dividend date 3 | 04 Dec 2022 |
| Ex-dividend date 4 | 02 Nov 2022 |
| Last split factor 2 | 1054:1000 |
| Last split date 3 | 16 Nov 2020 |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2021 |
| Most-recent quarter (mrq) | 01 Oct 2022 |
Profitability
| Profit margin | 29.81% |
| Operating margin (ttm) | 39.96% |
Management effectiveness
| Return on assets (ttm) | 13.32% |
| Return on equity (ttm) | 35.51% |
Income statement
| Revenue (ttm) | 99.88B |
| Revenue per share (ttm) | 17.81 |
| Quarterly revenue growth (yoy) | -5.80% |
| Gross profit (ttm) | 50.63B |
| EBITDA | 44.75B |
| Net income avi to common (ttm) | 29.95B |
| Diluted EPS (ttm) | 5.22 |
| Quarterly earnings growth (yoy) | 5.70% |
Balance sheet
| Total cash (mrq) | 36.13B |
| Total cash per share (mrq) | 6.44 |
| Total debt (mrq) | 37B |
| Total debt/equity (mrq) | 39.83 |
| Current ratio (mrq) | 1.59 |
| Book value per share (mrq) | 16.51 |
Cash flow statement
| Operating cash flow (ttm) | 26.6B |
| Levered free cash flow (ttm) | 22.83B |
© 2022 Yahoo. All rights reserved.
